Unlike other family members implicated in cancer, ADAM22 lacks a functional metalloproteinase domain [12] and may mediate its pro-tumourigenic effects through interaction with other cell surface tyrosine kinase receptors using its EGF-like domain [6]. Here, ADAM22 is linked to cancer.